Cyrnos-Esthetique
- Address
- 18 Avenue Saint Jean Baptiste, 06000 Nice, France
Platysma Prominence
At Cyrnos-Esthetique in Nice, researchers are focusing on the aesthetic improvement of moderate to severe platysma prominence. The trials aim to confirm that a single or repeated injectable treatment is safe and provides lasting neck contouring benefits.
- Evaluation of safety profile
- Assessment of efficacy after repeat administrations
- Comparison with placebo outcomes
Findings from these studies could expand non‑surgical options for patients seeking smoother neck appearance.
Glabellar Lines
The site also conducts research on the reduction of moderate to severe glabellar lines, commonly known as frown lines. The objective is to determine whether a single dose of a novel formulation improves facial expression dynamics and visual appearance.
- Measurement of wrinkle improvement
- Short‑term safety monitoring
- Patient satisfaction evaluation
Results are expected to guide future aesthetic treatments for forehead and eyebrow area rejuvenation.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Ipsen Innovation1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Cyrnos-Esthetique
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Phase III Study of Corabotase for Moderate to Severe Glabellar Lines in Adults | Ipsen Innovation | Phase III | Recruiting | Jun 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clostridium Botulinum, Neurotoxin Serotype A/B | 1 | Unknown | 2026-06-05 | 2026-06-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.